Tenet Healthcare Corporation

Historical 13F Holders

Symbol
THC
CUSIP
88033G407
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 88033G407 since 12/18/2024, newest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A Amendment 4 10.0% 9/4/2026
Event 8/31/2026
Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 9.2% 8/14/2026
Event 6/30/2026
FMR LLC 13G/A Amendment 1
4.6% 8/6/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.3% 4/30/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 16 0% 3/27/2026
Event 3/13/2026
Invesco Ltd. 13G/A Amendment 1 4.4% 5/9/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 3 8.8% 4/17/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 73 428 k $103 M
2026 Q2 726 99.1 M $15.6 B
2026 Q1 740 82.0 M $15.5 B
2025 Q4 759 85.1 M $16.9 B
2025 Q3 736 84.0 M $17.1 B
2025 Q2 681 87.5 M $15.4 B
2025 Q1 621 89.6 M $12.1 B
2024 Q4 640 91.1 M $11.5 B
2024 Q3 655 89.5 M $14.9 B
2024 Q2 583 94.9 M $12.6 B
2024 Q1 511 100 M $10.5 B
2023 Q4 480 96.9 M $7.32 B
2023 Q3 455 96.6 M $6.36 B
2023 Q2 459 96.5 M $7.84 B
2023 Q1 399 100 M $5.95 B
2022 Q4 403 108 M $5.29 B
2022 Q3 398 108 M $5.58 B
2022 Q2 418 106 M $5.57 B
2022 Q1 449 105 M $9.07 B
2021 Q4 426 104 M $8.41 B
2021 Q3 371 101 M $6.72 B
2021 Q2 351 100 M $6.72 B
2021 Q1 337 97.6 M $5.07 B
2020 Q4 323 102 M $4.07 B
2020 Q3 282 102 M $2.51 B
2020 Q2 272 102 M $1.86 B
2020 Q1 282 105 M $1.52 B
2019 Q4 298 105 M $3.99 B
2019 Q3 274 110 M $2.43 B
2019 Q2 281 107 M $2.21 B
2019 Q1 287 104 M $3.00 B
2018 Q4 294 106 M $1.83 B
2018 Q3 300 112 M $3.18 B
2018 Q2 296 107 M $3.61 B
2018 Q1 277 112 M $2.72 B
2017 Q4 282 120 M $1.82 B
2017 Q3 296 128 M $2.11 B
2017 Q2 286 117 M $2.27 B
2017 Q1 294 113 M $2.01 B
2016 Q4 300 103 M $1.53 B
2016 Q3 301 99.1 M $2.24 B
2016 Q2 288 101 M $2.78 B
2016 Q1 303 101 M $2.94 B
2015 Q4 324 106 M $3.20 B
2015 Q3 342 101 M $3.75 B
2015 Q2 385 98.4 M $5.70 B
2015 Q1 346 98.2 M $4.87 B
2014 Q4 360 95.9 M $4.86 B
2014 Q3 339 95.6 M $5.68 B
2014 Q2 318 99.2 M $4.66 B
2014 Q1 307 98.7 M $4.22 B